Tumor acid microenvironment-activated self-targeting & splitting gold nanoassembly for tumor chemo-radiotherapy
Source abstract
Abstract
Low accumulation and penetration of nanomedicines in tumor severely reduce therapeutic efficacy. Herein, a pH-responsive gold nanoassembly is designed to overcome these problems. Polyethylene glycol linked raltitrexed (RTX, target ligand and chemotherapy drug) and two tertiary amine molecules (1-(2-aminoethyl) pyrrolidine and N, N-dibutylethylenediamine) are modified on the surface of the 6-nm gold nanoparticles by lipoic acid to form gold nanoassembly defined as Au-NNP(RTX). The Au-NNP (RTX) nanoassembly could remain at about 160 nm at the blood circulation (pH 7.4), while split into 6-nm gold nanoparticles due to tertiary amine protonation at tumor extracellular pH (pH 6.8). This pH-responsive disassembly behavior endows Au-NNP(RTX) better tumor tissue permeability through the better diffusion brought by the size reduction. Meanwhile, after disassembly, more RTXs on the surface of gold nanoparticles are exposed from the shielded state of assembly along with 2.25-fold augment of cellular uptake capability. Most importantly, the results show that Au-NNP(RTX) possesses of high tumor accumulation and effective tumor penetration, thereby enhancing the tumor chemo-radiotherapy efficiency.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Perspectives on the past, present, and future of cancer nanomedicine10.1016/j.addr.2018.05.008 ↗
2. Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy10.1038/s41565-019-0485-z ↗
3. Subcellular performance of nanoparticles in cancer therapy10.2147/IJN.S226186 ↗
4. Integration of nanoassembly functions for an effective delivery cascade for cancer drugs10.1002/adma.201401554 ↗
5. The role of micelle size in tumor accumulation, penetration, and treatment10.1021/acsnano.5b02017 ↗
6. Light-activatable Assembled nanoparticles to improve tumor penetration and eradicate metastasis in triple negative breast cancer10.1002/adfm.201801738 ↗
7. Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment10.1016/j.actbio.2020.11.008 ↗
8. Highly penetrable and on-demand oxygen release with tumor activity composite nanosystem for photothermal/photodynamic synergetic therapy10.1021/acsnano.0c06415 ↗
9. Controllable assembly of upconversion nanoparticles enhanced tumor cell penetration and killing efficiency10.1002/advs.202001831 ↗
10. Dual-responsive polyprodrug nanoparticles with cascade-enhanced magnetic resonance signals for deep-penetration drug release in tumor therapy10.1021/acsami.0c16110 ↗
11. Size‐transformable nanostructures: from design to biomedical applications10.1002/adma.202003752 ↗
12. Light-assisted hierarchical intratumoral penetration and programmed antitumor therapy based on tumor microenvironment (TME)-amendatory and self-adaptive polymeric nanoclusters10.1016/j.biomaterials.2020.120166 ↗
13. Ultrasmall platinum nanoparticles enable deep tumor penetration and synergistic therapeutic abilities through free radical species-assisted catalysis to combat cancer multidrug resistance10.1016/j.cej.2019.123138 ↗
14. Surface charge of supramolecular nanosystems for in vivo biodistribution: a MicroSPECT/CT imaging study10.1002/smll.202003290 ↗
15. “Navigate-dock-activate” anti-tumor strategy: tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy10.7150/thno.33280 ↗
16. Spatially-resolved profiling of carbon nanotube uptake across cell lines10.1039/C7NR01561E ↗
17. An intelligent re-shieldable targeting system for enhanced tumor accumulation10.1016/j.jconrel.2017.10.009 ↗
18. Synthesis of polymeric micelles with dual-functional sheddable PEG stealth for enhanced tumor-targeted drug delivery10.1039/D0PY00653J ↗
19. Reversible shielding between dual ligands for enhanced tumor accumulation of ZnPc-loaded micelles10.1021/acs.nanolett.8b04645 ↗
20. A supramolecular platform for controlling and optimizing molecular architectures of siRNA targeted delivery vehicles10.1126/sciadv.abc2148 ↗
21. cRGD/TAT dual-ligand reversibly cross-linked micelles loaded with docetaxel penetrate deeply into tumor tissue and show high antitumor efficacy in vivo10.1021/acsami.7b12439 ↗
22. Control of targeting ligand display by pH-responsive polymers on gold nanoparticles mediates selective entry into cancer cells10.1039/C7NR02595E ↗
23. Size switchable nanoclusters fueled by extracellular ATP for promoting deep penetration and MRI‐guided tumor photothermal therapy10.1002/adfm.201904144 ↗
24. A NIR light triggered disintegratable nanoplatform for enhanced penetration and chemotherapy in deep tumor tissues10.1016/j.biomaterials.2020.119840 ↗
25. Tumor-activatable ultrasmall nanozyme generator for enhanced penetration and deep catalytic therapy10.1016/j.biomaterials.2020.120263 ↗
26. pH-Responsive charge switchable PEGylated ε-poly-l-lysine polymeric nanoparticles-assisted combination therapy for improving breast cancer treatment10.1016/j.jconrel.2020.07.030 ↗
27. Multistage-responsive clustered nanosystem to improve tumor accumulation and penetration for photothermal/enhanced radiation synergistic therapy10.1016/j.biomaterials.2020.120590 ↗
28. Shieldable tumor targeting based on pH responsive self-assembly/disassembly of gold nanoparticles10.1021/am5045339 ↗
29. pH-sensitive reversible programmed targeting strategy by the self-assembly/disassembly of gold nanoparticles10.1021/acsami.7b00687 ↗
30. pH-Sensitive assembly/disassembly gold nanoparticles with the potential of tumor diagnosis and treatment10.1007/s11426-018-9354-0 ↗
31. Stimuli-responsive polysaccharide enveloped liposome for targeting and penetrating delivery of survivin-shRNA into breast tumor10.1021/acsami.9b22440 ↗
32. Nucleoside analogue-based supramolecular nanodrugs driven by molecular recognition for synergistic cancer therapy10.1021/jacs.8b04556 ↗
33. Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance10.1016/j.drup.2012.07.002 ↗
34. Multivalent nanoparticles for personalized theranostics based on tumor receptor distribution behavior10.1039/C8NR09347D ↗
35. Biomimetic copper sulfide for chemo-radiotherapy: enhanced uptake and reduced efflux of nanoparticles for tumor cells under ionizing radiation10.1002/adfm.201705161 ↗